Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Light-induced breakdown of flavone acetic acid and xanthenone analogues in solution.

× No keyword cloud information.

14 in total

1. A phase I and pharmacokinetic study of 12-h infusion of flavone acetic acid.

Authors: I N Olver; L K Webster; J F Bishop; K H Stokes
Journal: Cancer Chemother Pharmacol Date: 1992 Impact factor: 3.333

2. Effects of anticancer drugs on the metabolism of the anticancer drug 5,6-dimethylxanthenone-4-acetic (DMXAA) by human liver microsomes.

Authors: S Zhou; R Chin; P Kestell; M D Tingle; J W Paxton
Journal: Br J Clin Pharmacol Date: 2001-08 Impact factor: 4.335

3. Labeling of oxidizable proteins with a photoactivatable analog of the antitumor agent DMXAA: evidence for redox signaling in its mode of action.

Authors: Romy Brauer; Liang-Chuan S Wang; See-Tarn Woon; David J A Bridewell; Kimiora Henare; Dieter Malinger; Brian D Palmer; Stefanie N Vogel; Claudine Kieda; Sofian M Tijono; Lai-Ming Ching
Journal: Neoplasia Date: 2010-09 Impact factor: 5.715

4. Plasma pharmacokinetics of the antitumour agents 5,6-dimethylxanthenone-4-acetic acid, xanthenone-4-acetic acid and flavone-8-acetic acid in mice.

Authors: M J McKeage; P Kestell; W A Denny; B C Baguley
Journal: Cancer Chemother Pharmacol Date: 1991 Impact factor: 3.333

5. Haematological effects in mice of the antitumour agents xanthenone-4-acetic acid, 5,6-dimethyl-xanthenone-4-acetic acid [correction of 5,6-methyl-] and flavone acetic acid.

Authors: L M Ching; M J McKeage; W R Joseph; P Kestell; L J Zwi; B C Baguley
Journal: Cancer Chemother Pharmacol Date: 1991 Impact factor: 3.333

6. Induction of tumour necrosis factor-alpha by single and repeated doses of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid.

Authors: M Philpott; B C Baguley; L M Ching
Journal: Cancer Chemother Pharmacol Date: 1995 Impact factor: 3.333

7. Interaction between endotoxin and the antitumour agent 5,6-dimethylxanthenone-4-acetic acid in the induction of tumour necrosis factor and haemorrhagic necrosis of colon 38 tumours.

Authors: L M Ching; W R Joseph; L Zhuang; B C Baguley
Journal: Cancer Chemother Pharmacol Date: 1994 Impact factor: 3.333

8. Production of tumour necrosis factor-alpha by cultured human peripheral blood leucocytes in response to the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid (NSC 640488).

Authors: M Philpott; W R Joseph; K E Crosier; B C Baguley; L M Ching
Journal: Br J Cancer Date: 1997 Impact factor: 7.640

9. Clinical aspects of a phase I trial of 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent.

Authors: M B Jameson; P I Thompson; B C Baguley; B D Evans; V J Harvey; D J Porter; M R McCrystal; M Small; K Bellenger; L Gumbrell; G W Halbert; P Kestell
Journal: Br J Cancer Date: 2003-06-16 Impact factor: 7.640

10. 6-methylhydroxylation of the anti-cancer agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) by flavin-containing monooxygenase 3.

Authors: Shufeng Zhou; Philip Kestell; James W Paxton
Journal: Eur J Drug Metab Pharmacokinet Date: 2002 Jul-Sep Impact factor: 2.569